Define the ‘’drug route to market’’

A regulatory roadmap is a powerful strategic document that identifies and summarizes the ''drug route to market''. The regulatory roadmap is exceptionally useful for developers to manage stakeholder relations such as investors, stockholders and potential collaboration partners. Therefore, a good roadmap increases the value of your project.

Contact a consultant

Depending on which stakeholder you want to approach, a regulatory roadmap comes in different shapes and sizes. Within the roadmap, you will find a list of recommendations. These recommendations can for example include: 

  • Regulatory strategy and legal basis for registering the proposed indications.
  • Potential expedited pathways and their likelihood of success.
  • A communication plan for scientific advice meetings and other kinds of interactions with authorities. 
  • Plan for pediatric studies.
  • Chances as well as pros and cons of getting a conditional (EU) or accelerated (US) approval.
  • Possibilities for data exclusivity and patent extensions. 

Pro-tip: Be prepared to change course

It's inevitable that contingencies will happen. Even so, when new information comes to your desk, you should be prepared to change the roadmap as it should be viewed as a living document that requires ongoing work. You see, being prepared to reevaluate your regulatory strategy strengthens the odds of you succeeding with your project. 

How to begin? A first meeting is a good start 👇


Contact our director of Regulatory Affairs

Send your inquiry to Erika Spens

We use cookies to ensure that we give you the best experience on our website. Read our cookie policy here.